Treatments

A modified version of the genetic engineering tool CRISPR may restore expression of the gene mutated in fragile X syndrome.

Folic acid, a B vitamin, may lower autism risk and ease features of the condition.

Children with autism who speak few or no words improve in their verbal abilities after their parents learn to engage them in conversation during play.

The U.S. Food and Drug Administration has granted a rare ‘breakthrough therapy’ designation for a drug that may ease some features of autism.

Adults with autism who undergo a therapy designed to bolster social learning show cognitive benefits that may increase their chances of employment.

The drug rapamycin, which is in clinical trials as a treatment for tuberous sclerosis, may exacerbate features of fragile X syndrome, another condition related to autism.